Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Immuno-Oncology Congress 2022

Cancer vaccines: Promise or dead end?

Promise

Date

07 Dec 2022

Session

Cancer vaccines: Promise or dead end?

Topics

Tumour Immunology;  Translational Research;  Immunotherapy

Tumour Site

Head and Neck Cancers

Presenters

Christian Ottensmeier

Authors

C.H.H. Ottensmeier

Author affiliations

  • University of Liverpool, Liverpool/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction and first vote

Presenter: Stephen Schoenberger

Session: Cancer vaccines: Promise or dead end?

Resources:

Webcast

Second vote and conclusions

Presenter: Stephen Schoenberger

Session: Cancer vaccines: Promise or dead end?

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.